脑蛋白水解物通过p38 MAPK信号通路降低阿尔茨海默病小鼠的细胞凋亡、炎症及氧化应激水平

doi:10.3969/j.issn.1006-7795.2024.06.016

首都医科大学学报 ›› 2024, Vol. 45 ›› Issue (6): 1062-1070.doi: 10.3969/j.issn.1006-7795.2024.06.016

脑蛋白水解物通过p38 MAPK信号通路降低阿尔茨海默病小鼠的细胞凋亡、炎症及氧化应激水平

苟东芸¹, 梁加一^2,3, 郭梓煜^2,3, 闫方圆^2,3, 王帅翔^2,3, 渠硕^2,3, 高雁², 张雨佳⁴, 马晓伟^2,5,6*

1.河北医科大学第一医院神经内科，石家庄 050031；2.首都医科大学宣武医院河北医院神经内科，石家庄 050031；3.河北医科大学研究生学院，石家庄 050017；4.衡水市第五人民医院神经内科，河北衡水 053000；5.河北省脑老化与认知神经科学实验室，石家庄 050031；6.河北省神经医学技术创新中心，石家庄 050031

收稿日期:2024-04-08 出版日期:2024-12-21 发布日期:2024-12-19
通讯作者: 马晓伟 E-mail:maxiaowei8006@163.com
基金资助:
河北省自然科学基金重点项目（H2020206597）, 河北医科大学创新性实验计划项目（USIP2022163）。

The p38 MAPK signaling pathway mediates the reduction of apoptosis, inflammation and oxidative stress levels in AD mice by cerebroprotein

Gou Dongyun¹, Liang Jiayi^2,3, Guo Ziyu^2,3, Yan Fangyuan^2,3, Wang Shuaixiang^2,3 , Qu Shuo^2,3，Gao Yan², Zhang Yujia⁴, Ma Xiaowei*^2,5,6*

1.Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang 050031, China; 2.Department of Neurology, Hebei Hospital of Xuanwu Hospital, Capital Medical University, Shijiazhuang 050031, China; 3.Graduate School, Hebei Medical University, Shijiazhuang 050017, China; 4. Department of Neurology, The Fifth People's Hospital of Hengshui, Hengshui 053000, Hebei Province, China;5.Brain Aging and Cognitive Neuroscience Laboratory of Heibei Province, The First Hospital of Hebei Medical University, Shijiazhuang 050031, China; 6.Neuromedical Technology Innovation Center of Hebei Province, Shijiazhuang 050031, China

Received:2024-04-08 Online:2024-12-21 Published:2024-12-19
Supported by:
This study was supported by the Hebei Provincial Natural Science Foundation (H2020206597), the Innovative Experimental Program for College Students in Hebei Province (USIP2022163).

摘要/Abstract

摘要： 目的探讨脑蛋白水解物（cerebroprotein hydrolysate for injection I, CH-I）对阿尔茨海默病（Alzheimer's disease, AD）小鼠学习记忆能力、凋亡和氧化应激的影响及机制。方法采用β淀粉样蛋白(β-Amyloid，Aβ_1-42) 海马内注射建立AD小鼠模型，实验分为对照（control，Con）组、Aβ组、Aβ+CH-I组、CH-I组。以新物体实验和Y迷宫检测小鼠学习记忆能力；酶联免疫吸附试验检测脑组织超氧化物歧化酶(superoxide dismutase, SOD) 、谷胱甘肽过氧化物酶（glutathione peroxidase, GSH-Px）、过氧化氢酶（catalase, CAT）活力； Tunel染色检测细胞凋亡水平；提取Aβ组和Aβ+CH-I组小鼠海马mRNA进行转录组测序（RNA sequencing， RNA-seq）及生物信息学分析和验证；通过蛋白质免疫印迹(Western blotting,WB）实验检测应激活化蛋白激酶(c-Jun N-terminal kinase, JNK)、丝裂原活化蛋白激酶(mitogen-activated protein kinase, MAPK)、p38 MAPK磷酸化蛋白和总蛋白及炎性反应表达。结果与Con组和 Aβ+CH-I 组比较，Aβ小鼠组新异臂/物体探索时间百分比显著降低；Aβ组小鼠SOD、GSH-Px活性显著低于Con组和Aβ+CH-I组，差异有统计学意义；RNA-seq 测序显示与Aβ组相比，Aβ+CH-I组MAPK信号通路及炎性因子相关基因显著下调；通过WB证实与 Aβ组相比，Aβ+CH-I组凋亡水平、p38 MAPK蛋白及炎性反应水平显著下降。结论 CH-I可能通过调控p38 MAPK信号通路保护神经元免受氧化应激及凋亡从而介导神经细胞的保护作用。

关键词: 阿尔茨海默病, p38 MAPK信号通路, 脑蛋白水解物, 氧化应激, 细胞凋亡, 炎性反应

Abstract: Objective Our objective was to examine the potential of cerebroprotein hydrolysate for injection I (CH-I) in mitigating oxidative stress, apoptosis, and neuroinflammation in an Alzheimer's disease (AD) model, while also gaining a better understanding of the underlying mechanisms. Methods AD mouse model was established through the intrahippocampal injection of amyloid-β_1-42. The experiment consisted of four groups: Control (Con) group, Aβ group, Aβ+CH-I group, and CH-I group. The learning and memory abilities of the mice were assessed using the new object recognition experiment and Y-maze. Enzyme-linked immunosorbent assay was employed to measure the activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), thioredoxin, and catalase (CAT) in brain tissue. Additionally, Tunel staining was utilized to evaluate the levels of cell apoptosis. Aβ group and Aβ+CH-I group were extracted for RNA-seq and bioinformatics analysis and verification.Western blotting analysis was conducted to detect proteins associated with the pathway ［c-Jun N-terminal kinase (JNK), mitogen-activated protein kinase (MAPK), p38 MAPK］. Results In comparison to the Con group and the Aβ+CH-I group, the Aβ group exhibited a significant decrease in the proportion of time allocated to exploring novel arms/objects. Moreover, the Aβ group displayed significantly lower levels of SOD and GSH-Px activities in mice, in contrast to both the Con group and the Aβ+CH-I group, with statistically significant distinctions. The RNA-seq analysis demonstrated a significant downregulation of the MAPK signaling pathway in the Aβ+CH-I group compared to the Aβ group. Additionally, the Aβ+CH-I group exhibited noteworthy reductions in apoptosis levels, p38 MAPK protein, and inflammation levels when compared to the Aβ group. Conclusions CH-I exerts neuroprotective effects through the modulation of the p38 MAPK signaling pathway, thereby conferring neuronal resistance against oxidative stress and apoptosis.

Key words: Alzheimer's disease, p38 MAPK, CH-I, oxidative, apoptosis, inflammation

中图分类号:

R741

苟东芸, 梁加一, 郭梓煜, 闫方圆, 王帅翔, 渠硕, 高雁, 张雨佳, 马晓伟. 脑蛋白水解物通过p38 MAPK信号通路降低阿尔茨海默病小鼠的细胞凋亡、炎症及氧化应激水平[J]. 首都医科大学学报, 2024, 45(6): 1062-1070.

Gou Dongyun, Liang Jiayi, Guo Ziyu, Yan Fangyuan, Wang Shuaixiang , Qu Shuo, Gao Yan, Zhang Yujia, Ma Xiaowei. The p38 MAPK signaling pathway mediates the reduction of apoptosis, inflammation and oxidative stress levels in AD mice by cerebroprotein[J]. Journal of Capital Medical University, 2024, 45(6): 1062-1070.

参考文献

［1］ Saha S K A, Sadhukhan P, Sinha K, et al. Mangiferin attenuates oxidative stress induced renal cell damage through activation of PI3K induced Akt and Nrf-2 mediated signaling pathways［J］. Biochem Biophys Rep, 2016, 5: 313－327.
［2］ Gavrilova S I, Alvarez A. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use［J］. Med Res Rev, 2021, 41(5): 2775－2803.
［3］ Brainin M. Cerebrolysin: a multi-target drug for recovery after stroke［J］. Expert Rev Neurother, 2018, 18(8): 681－687.
［4］ Jing D Q, Bai H, Yin S N. Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3β and Bax/caspase-3 signaling pathways［J］. Exp Ther Med, 2017, 14(5): 5163－5169.
［5］ Uddin M N, Afrin R, Uddin M J, et al. Vanda roxburghii chloroform extract as a potential source of polyphenols with antioxidant and cholinesterase inhibitory activities: identification of a strong phenolic antioxidant［J］. BMC Complement Altern Med, 2015, 15: 195.
［6］ Jing H Y, Wang F H, Gao X J. Lithium intoxication induced pyroptosis via ROS/NF-κB/NLRP3 inflammasome regulatory networks in kidney of mice［J］. Environ Toxicol, 2022, 37(4): 825－835.
［7］ Liu X J, Wang Y Q, Shang S Q, et al. TMT induces apoptosis and necroptosis in mouse kidneys through oxidative stress-induced activation of the NLRP3 inflammasome［J］. Ecotoxicol Environ Saf, 2022, 230: 113167.
［8］ Totsuka K, Ueta T, Uchida T, et al. Oxidative stress induces ferroptotic cell death in retinal pigment epithelial cells［J］. Exp Eye Res, 2019, 181: 316－324.
［9］ Abdelmegeed M, Mukhopadhyay P. Understanding the roles and mechanisms of oxidative stress in diseases, tissue injury, and cell death in vivo and in vitro: Therapeutic possibilities of antioxidants［J］. Food Chem Toxicol, 2019,127:70－71.
［10］ Morgan M J, Kim Y S, Liu Z. Lipid rafts and oxidative stress-induced cell death［J］. Antioxid Redox Signal, 2007, 9(9): 1471－1483.
［11］ Kotora P, Šeršeň F, Filo J, et al. The scavenging of DPPH, galvinoxyl and ABTS radicals by imine analogs of resveratrol［J］. Molecules, 2016, 21(1): E127.
［12］ Chen Y, Yang J, Huang Z, et al. Exosomal lnc-AFTR as a novel translation regulator of FAS ameliorates Staphylococcus aureus-induced mastitis［J］. Biofactors, 2022, 48(1): 148－163.
［13］ Zhang Q R, Xue Y, Fu Y X, et al. Zinc deficiency aggravates oxidative stress leading to inflammation and fibrosis in lung of mice［J］. Biol Trace Elem Res, 2022, 200(9): 4045－4057.
［14］ Chen Y, Jing H Y, Chen M Y, et al. Transcriptional profiling of exosomes derived from staphylococcus aureus-Infected bovine mammary epithelial cell line MAC-T by RNA-Seq analysis［J］. Oxid Med Cell Longev, 2021, 2021: 8460355.
［15］ Li R, Jia Z Q, Trush M A. Defining ROS in biology and medicine［J］. React Oxyg Species (Apex), 2016, 1(1): 9－21.
［16］ Lei P, Ayton S, Bush A I. The essential elements of Alzheimer's disease［J］. J Biol Chem, 2021, 296: 100105.
［17］ Guan X, Wang Y J, Kai G Y, et al. Cerebrolysin ameliorates focal cerebral ischemia injury through neuroinflammatory inhibition via CREB/PGC-1α pathway［J］. Front Pharmacol, 2019, 10: 1245.
［18］ Tramutola A, Lanzillotta C, Perluigi M, et al. Oxidative stress, protein modification and Alzheimer disease［J］. Brain Res Bull, 2017, 133: 88－96.
［19］ Gavrilova S I, Alvarez A. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use［J］. Med Res Rev, 2021, 41(5): 2775－2803.
［20］ Rockenstein E, Ubhi K, Trejo M, et al. CerebrolysinTM efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure［J］. BMC Neurosci, 2014, 15: 90.
［21］ Isaev N K, Stelmashook E V, Genrikhs E E. Role of nerve growth factor in plasticity of forebrain cholinergic neurons［J］. Biochemistry (Mosc), 2017, 82(3): 291－300.
［22］ Xu C J, Wang J L, Jin W L. The emerging therapeutic role of NGF in alzheimer's disease［J］. Neurochem Res, 2016, 41(6): 1211－1218.
［23］ Ubhi K, Rockenstein E, Vazquez-Roque R, et al. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease［J］. J Neurosci Res, 2013, 91(2): 167－177.
［24］ Rockenstein E, Torrance M, Mante M, et al. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease［J］. J Neurosci Res, 2006, 83(7): 1252－1261.
［25］ Wei Z H, He Q B, Wang H, et al. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease［J］. J Neural Transm, 2007, 114(5): 629－634.
［26］ Gauthier S, Proaño J V, Jia J P, et al. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials［J］. Dement Geriatr Cogn Disord, 2015, 39(5/6): 332－347.
［27］ Zhu L, Liu Y J, Wu X L, et al. Cerebroprotein hydrolysate-I protects senescence-induced by D-galactose in PC12 cells and mice［J］. Food Sci Nutr, 2021, 9(7): 3722－3731.
［28］ Rezatabar S, Karimian A, Rameshknia V, et al. RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression［J］. J Cell Physiol, 2019, 234(9): 14951－14965.
［29］ Sabitha R, Nishi K M I, Gunasekaran V P, et al. p-Coumaric acid attenuates alcohol exposed hepatic injury through MAPKs, apoptosis and Nrf2 signaling in experimental models［J］. Chem Biol Interact, 2020, 321: 109044.
［30］ Ma X, Zhang Y, Gou D, et al. Metabolic reprogramming of microglia enhances proinflammatory cytokine release through EphA2/p38 MAPK pathway in Alzheimer's disease［J］. J Alzheimers Dis, 2022, 88(2): 771－785.
［31］ Yong H Y, Koh M S, Moon A. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer［J］. Expert Opin Investig Drugs, 2009, 18(12): 1893－1905.
［32］ Yasuda S, Sugiura H, Tanaka H, et al. p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases［J］. Cent Nerv Syst Agents Med Chem, 2011, 11(1): 45－59.
［33］ Guan X, Wang Y J, Kai G Y, et al. Cerebrolysin ameliorates focal cerebral ischemia injury through neuroinflammatory inhibition via CREB/PGC-1α pathway［J］. Front Pharmacol, 2019, 10: 1245.

[1]	关乐, 宋天彬, 候亚琴, 李则, 闫少珍, 张春. ¹¹C-PIB PET定性及半定量分析在鉴别诊断阿尔茨海默病中的价值[J]. 首都医科大学学报, 2024, 45(1): 19-24.
[2]	刘秀, 李文才. UNC0379对胶质瘤细胞增殖影响的初步探索[J]. 首都医科大学学报, 2023, 44(5): 741-746.

脑蛋白水解物通过p38 MAPK信号通路降低阿尔茨海默病小鼠的细胞凋亡、炎症及氧化应激水平

The p38 MAPK signaling pathway mediates the reduction of apoptosis, inflammation and oxidative stress levels in AD mice by cerebroprotein

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价